ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients

August 12, 1983

DeVita Will Ask NTP To Return Some NCI Funs To help Cover Shortfall In Center Core Budget

January 18, 1980

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983

Reagan Signs Skins Cancer Resolution

March 29, 1985